Simeon J. George
Board Member at CRISPR Therapeutics
Dr. Simeon George has served on our Board of Directors since April 2015. Simeon currently serves as a Partner at SR One, where he has been employed since 2007. In addition, Dr. George previously served as a director on the boards of the following biotechnology companies: Semprus BioSciences (acquired by Teleflex in June 2012), HTG Molecular Diagnostics and Genocea Biosciences. He also served as a consultant at Bain & Company from October 2006 to August 2007. Simeon received an M.D. from the University of Pennsylvania School of Medicine, an M.B.A. as a Mayer Scholar from the Wharton School of the University of Pennsylvania and a B.A. in Neuroscience from Johns Hopkins University.